Vitamin D supplements may not be an effective defense against acute respiratory infections, a recent study has found.
It’s still possible the vitamin supplementation could reduce the severity and duration of such infections, “but [we] did not address this question,” said Adrian Martineau, a clinical professor of respiratory infection at Queen Mary University of London and the study’s senior author.
The paper appeared in the Lancet Diabetes & Endocrinology journal. It analyzed data pooled from nearly four dozen clinical trials involving more than 60,000 participants.
Despite this finding, vitamin D does provide other important health benefits. It helps prevent musculoskeletal diseases such as rickets and osteomalacia, for example, and is essential for absorbing calcium, reducing the risk of osteoporosis and fractures that can result from this bone-thinning disease.
“So if people are already taking a vitamin D supplement for musculoskeletal health, either prescribed or over-the-counter, they should not stop taking it,” Martineau said. “Our findings relate only to the question of protection against” acute respiratory infections.
A common supplement
Vitamin D is one of the supplements most commonly taken by U.S. adults, according to the Centers for Disease Control and Prevention. The recommended dietary allowance for vitamin D per day is 600 international units (IU) for most ages, 400 IU for infants and 800 IU for those older than 70.
A 2021 paper by the same team had found a slight but statistically significant protective effect against acute respiratory infections from taking vitamin D supplements.
But the most recent analysis added the results of three new large trials to the previous data and found a negligible — or nonstatistically significant — protective effect overall from the supplements.